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Several groups of polyhalogenated aromatic
hydrocarbons, including dioxins and poly-
chlorinated biphenyls (PCBs), are known to
induce developmental toxicity (e.g., Peterson
et al. 1993; Schantz 1996). These com-
pounds also exert endocrine-modulating
effects that are likely to underlie some of their
developmental actions (e.g., Gore 2001; Li
et al. 1997; Porterfield 2000; Schantz and
Widholm 2001). For instance, a mixture of
PCBs reconstituted according to the congener
pattern found in human breast milk has been
shown to cause reductions in circulating sex
steroids and alterations in sexual differen-
tiation of the brain and sexually dimorphic
behavior in rats (Hany et al. 1999; Kaya et al.
2002). Although concentrations of dioxins
and PCBs in environmental samples are
decreasing, marked increases have been
reported for brominated flame retardants in
recent years and, in particular, for polybromi-
nated diphenyl ethers (PBDEs) (Noren and
Meironyte 2000; Schecter et al. 2003; Sjödin
et al. 2004). The PBDE molecule has two
phenol rings linked by an oxygen atom and a
variable number of bromine substituents that
can bind at 10 different positions. Depending
on the number and position of bromine
atoms, 209 different congeners can be formed,
but only a few of them are present in com-
mercial mixtures. For instance, the major con-
stituents of the commercial PBDE mixture
DE-71 are pentabrominated PBDE-99
(2,2´,4,4´,5-pentabromodiphenyl ether) and
tetrabrominated PBDE-47, which together
account for approximately 85% of the mix-
ture. The remaining 15% of the mixture con-
sists mainly of pentabrominated PBDE-100
and, in decreasing proportions, the hexa-
brominated congeners PBDE-153 and
PBDE-154 (Sjödin et al. 2003).
Knowledge about developmental toxicity
of PBDE is limited (Birnbaum and Staskal
2004), but initial results indicate that DE-71
causes effects on thyroid hormones, sex
steroids, and development of reproductive
organs (Stoker et al. 2004; Zhou et al. 2002).
Exposure to single PBDE congeners in mice
affects neurobehavioral development (Branchi
et al. 2002, 2004; Viberg et al. 2004) and
cholinergic receptors in the brain (Viberg et al.
2002, 2003) in a similar fashion to that
described after developmental exposure to
PCBs in rats and mice (Brouwer et al. 1995;
Eriksson and Frederiksson 1998). The purpose
of the present study was to evaluate whether
PBDE-99, which is one of the most abundant
PBDEs in the environment, also affects end
points that have been shown to be changed by
the reconstituted PCB mixture, namely, circu-
lating steroids, steroid-dependent behavior,
and reproductive organ development. We
chose sweet preference to examine sexually
dimorphic behavior because a marked sex dif-
ference is observed in adult rats, with males
consuming smaller amounts of sweetened
solutions than females (Valenstein et al.
1967). This behavior has been shown to be
sensitive to perinatal exposure to nicotine
(Lichtensteiger and Schlumpf 1993) or a
reconstituted PCB mixture (Hany et al. 1999;
Kaya et al. 2002). Both treatments caused ele-
vated sweet preference in adult males, along
with a reduction of aromatase activity observed
in the brain of newborn male pups (Hany
et al. 1999; Lichtensteiger and Schlumpf
1993). Precise measurement of sweet prefer-
ence is easy to conduct and can be determined
in home cages without handling the animals.
We also evaluated ovarian follicle numbers in
adult female offspring because alterations in fol-
liculogenesis have been observed after exposure
to the commercial PCB mixture Aroclor 1016
(Baldridge et al. 2003). Changes in follicular
maturation provide an indication of direct
effects on the ovary or indirect effects due to
disturbance of the hypothalamic-pituitary-
ovary axis that may occur after exposure to
PBDE-99. For comparison, we included a
group exposed to the commercial mixture
Aroclor 1254 (A1254) in the present study.
Materials and Methods
Animals and treatments. All procedures invol-
ving rats were approved by the local authorities
according to the German legal requirements
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Increasing concentrations of polybrominated ﬂame retardants, including polybrominated diphenyl
ethers (PBDEs), in breast milk cause concern about possible developmental effects in nursed babies.
Because previous studies in rats have indicated effects on sex steroids and sexually dimorphic behav-
ior after maternal exposure to polychlorinated biphenyls (PCBs), our goal in the present study was to
determine if developmental exposure to 2,2´,4,4´,5-pentabromodiphenyl ether (PBDE-99) induces
similar endocrine-mediated effects. Pregnant rats were exposed to vehicle or PBDE-99 (1 or
10 mg/kg body weight, daily during gestational days 10–18). For comparison, we also included a
group exposed to the technical PCB mixture Aroclor 1254 (30 mg/kg body weight, daily). PBDE
exposure resulted in pronounced decreases in circulating sex steroids in male offspring at weaning
and in adulthood. Female offspring were less affected. Anogenital distance was reduced in male off-
spring. Puberty onset was delayed in female offspring at the higher dose level, whereas a slight accel-
eration was detected in low-dose males. The number of primordial/primary ovarian follicles was
reduced in females at the lower dose, whereas decline of secondary follicles was more pronounced at
the higher dose. Sweet preference was dose-dependently increased in PBDE-exposed adult males,
indicating a feminization of this sexually dimorphic behavior. Aroclor 1254 did not alter sweet pref-
erence and numbers of primordial/primary and secondary follicles but it did affect steroid concentra-
tions in males and sexual development in both sexes. PBDE concentrations in tissues of dams and
offspring were highest on gestational day 19. These results support the hypothesis that PBDEs are
endocrine-active compounds and interfere with sexual development and sexually dimorphic behav-
ior. Key words: ovarian follicles, polybrominated diphenyl ether, polychlorinated biphenyls, rats, sex
steroids, sexual development, sexually dimorphic behavior. Environ Health Perspect 114:194–201
(2006). doi:10.1289/ehp.8391 available via http://dx.doi.org/ [Online 6 October 2005]for animal experiments (Tierschutzgesetz,
Bundesgesetzblatt 1998, I.S. 1105). Animals
used in the study were treated humanely and
with regard for alleviation of discomfort and
suffering. We obtained pregnant Long-Evans
hooded rats (n = 108) from the breeder
(Janvier, La Geneste St. Isle, France). They
were housed in single plastic cages with a bed-
ding of sawdust. The animals were exposed to
12-hr light/dark periods starting with lights
on at 0600 hr. The ambient room tempera-
ture was 23°C, and the relative humidity was
55%. Food and water were available ad libi-
tum. Weight-matched groups of dams
(n = 27/group) received daily subcutaneous
injections of vehicle (olive oil), PBDE-99 at
doses of 1 or 10 mg/kg body weight (BDE01
and BDE10 groups, respectively), or the tech-
nical PCB mixture Aroclor 1254 (A1254; lot
W-135-11) at a dose of 30 mg/kg body
weight from gestational day (GD) 10 through
GD18. The doses of PBDE-99 used in this
study were based on a previous report describ-
ing neurobehavioral effects of this congener in
mice (Eriksson et al. 2001). The doses
selected take into account the longer treat-
ment period and the maternal exposure in our
rats, in contrast to the single exposure and
direct treatment of neonatal mice. The dose
of A1254 is in the same range as the dose pre-
viously used in our laboratory for the
comparison with the reconstituted PCB mix-
ture (Hany et al. 1999), when adjusted for
the shorter exposure period in the present
study. Chemicals were obtained from
Promochem (Wesel, Germany). The PBDE-
99 (lot 001) had a purity of approximately
99% and was analyzed with high-resolution
gas chromatography (GC)/high-resolution
mass spectrometry (MS) by a commercial
analytical laboratory (Oekometric, Bayreuth,
Germany) for polybrominated dioxins, poly-
brominated dibenzofurans, and coplanar
polybrominated biphenyls. All contaminants
were below the detection limits: 0.05 mg
2,3,7,8-tetrabromodibenzo-p-dioxin/kg
PBDE-99 and 5 mg octabromodibenzo-p-
dioxin/kg PBDE-99. For the respective chlo-
rinated compounds, this would yield a
maximum total toxic equivalent (TEQ) of
0.50 mg/kg PBDE-99, calculated as North
Atlantic Treaty Organization TEQ for
dibenzo-p-dioxins and dibenzofurans, and of
0.01 mg/kg PBDE-99, calculated as World
Health Organization TEQ for biphenyls.
On GD19, three dams per group were
sacriﬁced, and blood was taken by heart punc-
ture for hormone analysis. Blood samples were
centrifuged twice at 3,500 rpm for 15 min,
and the supernatant stored at –30°C until
analysis. Maternal pituitaries and brains were
collected and weighed. Brains and perirenal
adipose tissue were deep-frozen until deter-
mination of maternal PBDE concentrations.
The fetuses were counted and sacriﬁced, and
their brains were removed and pooled on a lit-
ter basis for determination of PBDE concen-
trations in offspring. On the day of birth,
which was assigned postnatal day (PND) 0, lit-
ter sizes and weights were determined and the
pups were examined for gross malformations.
There was no general standardization of litters;
however, litters with > 10 pups were culled to
10, and litters with < 5 pups were not used.
Measurement of litter weights was repeated on
PNDs 7, 14, and 21. At weaning (PND21),
necropsies were repeated in randomly selected
dams and offspring. Blood was taken from
eight dams per group and one male and one
female pup from each of their litters for hor-
mone analyses. Brains and perirenal adipose
tissue from dams and offspring were deep-
frozen for PBDE analyses. Uteri of the dams
were examined for the number of implan-
tations. The pituitary, thymus, testes, ventral
prostate, and uterus were removed from pups
to determine organ weights. After weaning, the
offspring were separated by sex and housed in
group cages (four or five per cage) until the
beginning of the behavioral tests. Dissections
were repeated in adult offspring and included
the removal of thyroid glands, and removal of
ovaries to determine follicle numbers. Dams
and offspring were randomly assigned to all
treatments, dissections, and measurements.
The only exception was that dams were
weight-matched before they were assigned to
one of the exposure groups to prevent possible
confounding of PBDE-99 effects by differences
not related to exposure.
Sexual development. We measured anogen-
ital distance, a marker of sexual development,
in weanling pups and adult offspring used for
dissections. We did not measure anogenital
distance in neonatal pups because of the lim-
ited precision of the smaller absolute values. In
addition, the onset of puberty was determined
by daily examination of female pups from
PND30 onward for vaginal opening and of
male pups for balanopreputial separation start-
ing on PND40. For this, one to ﬁve pups of
either sex were used per litter, depending on
the number of available male and female pups.
Analysis of sex steroids. We used commer-
cial enzyme-linked immunosorbent assay
(ELISA) kits (DRG, Marburg, Germany) for
determination of serum concentrations of
17β-estradiol and testosterone. Because these
kits were developed for human serum, we used
a previously established method (Hany et al.
1999) that involved extraction and enrichment
of steroids from rat serum in diethyl ether to
avoid protein matrix effects and to obtain an
appropriate concentration range. To measure
for speciﬁcity, we determined recovery rates in
pooled sera (98–105% for testosterone and
105–112% for 17β-estradiol). Recovery rates
> 100% were due to residual cross-reactivity
with structurally similar steroids. In the case of
estradiol, the zero standard of the ELISA kit
contained some residual 17β-estradiol that was
revealed during the extraction and enrichment
procedure.
Ovarian follicles. Whole ovaries (n = 8 for
each group) were fixed in Bouin’s solution,
dehydrated in ethanol, and embedded in paraf-
ﬁn. Serial sections were made every 6 µm and
stained with hemotoxylin and eosin. Primordial
and primary follicles were counted in ﬁve sec-
tions, 240 µm apart, taken from the middle of
the ovary. Every tenth section (60 µm apart) of
the entire ovary was analyzed to evaluate the
numbers of secondary, tertiary, and atretic fol-
licles. To avoid duplication, we counted only
follicles in which the nucleolus could be seen.
Ovarian follicles were classiﬁed according
to a modiﬁcation (Plowchalk et al. 1993) of a
previously established scheme (Pedersen and
Peters 1968). Primordial follicles and primary
follicles were counted together and were identi-
ﬁed by oocytes surrounded by a single layer of
either squamous or cuboidal epithelial cells.
The oocytes of secondary follicles were sur-
rounded by more than one layer of granulosa
cells or by one layer plus an incomplete second
layer with signs of theca interna development.
Tertiary follicles were distinguished by antral
formation. Atretic follicles were characterized
by the appearance of pyknotic granulosa cells,
disorganized granulosa cells, and detachment
from the basement membrane, a degenerating
oocyte surrounded by an envelope of degener-
ating cumulus cells or loss of cumulus cells
(Borgeest et al. 2002; Devine et al. 2000).
Sweet preference test. The method to
determine sweet preference was performed as
described previously by Kaya et al. (2002).
Starting on PND120, 9–11 males and 10–12
females per group (not more than 1 male and
1 female taken from a litter) were housed in
single cages and each was given two bottles
ﬁlled with tap water. During this adaptation
period of 7 days, basal water intake was deter-
mined. After adaptation, each rat was given a
bottle ﬁlled with tap water and another bottle
ﬁlled with 0.25% saccharin solution in water
(Fluka, Seelze, Germany). Position of the bot-
tles was counterbalanced in each group and
changed on every second day to prevent posi-
tion preferences. Solutions were prepared
daily, and tap water was also changed each day
during the test period of 5 days. Food was
available ad libitum throughout the testing
time. Weight of rats was determined on the
day before and on the day after the test. The
ratio of saccharin to water intake was used to
determine sweet preference. The test was con-
ducted by an investigator who was unaware of
the exposure conditions.
Analysis of PBDE-99 in tissues. A sub-
sample of brain and adipose tissue was
homogenized and extracted with a 7:2 mixture
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trifuged, and an aliquot was shaken with con-
centrated sulfuric acid to remove fatty
components. The extract was then analyzed by
capillary GC with MS in single-ion detection
mode (SIM) to establish approximate concen-
trations of PBDE-99. These rough estimates
were the basis for the further preparation of
the samples. An internal standard, either
PCB-209 or 13C-labeled PBDE-99 was added
to the extract. The mixture was shaken, cen-
trifuged, decanted, and concentrated. For the
cleanup, this concentrated extract was poured
onto a combination of two solid-phase extrac-
tion (SPE) columns. The first SPE column
(SiOH–H) contained a mixture of silica phase
impregnated with sulfuric acid and a strongly
acidic cation exchanger based on silica with
benzene sulfonic acid modification. This
SiOH–H column was used together with a sil-
ica-phase (SiOH) column. For analysis, the
cleaned extract was diluted or concentrated
depending on the estimated PBDE-99 concen-
tration in the tissue. Instrumental analysis was
performed using capillary GC with an electron
capture detector. If the result was uncertain,
analysis was performed again using GC/MS-
SIM. In this case we used 13C-PBDE as the
internal standard. For quality control, two
samples consisting of neat bacon fat and bacon
fat spiked with native PBDE-99 were analyzed
in each series of determinations (10–15 sam-
ples). The detection limit was 5 ng PBDE-99/g
lipid, and the recovery rate was 100% based on
the analysis of the spiked bacon fat.
Statistical analysis. We used the SAS sta-
tistical package (version 6.2; SAS Institute,
Cary, NC, USA) for all statistical evaluations.
The litter was the statistical unit in analyses of
all data in offspring, and sex was nested within
litter. We analyzed the development of body
weights in pregnant dams by two-way analysis
of variance (ANOVA) with repeated measures
and exposure as the between factor and time
as the within factor. After significant main
effects, we performed post hoc comparisons of
groups with the Ryan-Einot-Gabriel-Walsh
test. Development of body weights in off-
spring was analyzed with three-way ANOVA
with repeated measures (exposure as between-
litter factor and sex and time as within-litter
factors). This was followed by preplanned sep-
arate analyses in male and female pups. In
addition, we analyzed these data with a pre-
planned analysis of covariance with litter size
as the covariate. The ratio of organ to body
weight was calculated to yield relative organ
weights, and the resulting values were analyzed
by one-way ANOVA with exposure as the
between factor. One-way ANOVA was also
used for analyses of steroid concentrations
with exposure as the between factor. To evalu-
ate data on vaginal opening and preputial
separation, we calculated a mean across the
values obtained in one litter, so that these sta-
tistics were entirely litter based. Results were
evaluated with a nonparametric test (van der
Waerden test using normalized scores) that
was also used for analyses of anogenital dis-
tance and of ovarian follicles because these
data were not normally distributed. For analy-
sis of sweet preference data, we summed the
consumption of saccharin solution and that of
water intake across the 5 days of testing and
then calculated the ratio of saccharin to water
intake to obtain a measure for the preference.
These preference values were analyzed by two-
way ANOVA with exposure as between-litter
factor and sex as within-litter factor. This was
followed by preplanned separate analyses of
preference in males and females with one-way
ANOVA and exposure as the between factor.
We considered an error probability of p < 0.05
signiﬁcant in all analyses.
Results
Developmental data. Body weight of dams and
body weight gain during gestation were not
inﬂuenced by exposure to PBDE-99 or A1254
(Table 1). The number of implantations per
litter, the number of pups per litter, and the
percentage of male pups were not different
from controls. On PND7, body weights were
slightly reduced in male and female pups
exposed to A1254 compared with controls (p <
0.05). No significant differences between
A1254 and controls were found at other time
points. The lower dose of PBDE-99 induced a
slight increase in body weight in female pups at
birth (p < 0.05) but not at later time points.
Compared with A1254, both doses of PBDE-
99 increased body weights in male pups in the
ﬁrst 2 weeks after birth (p < 0.05). In female
pups, this was seen only at the lower dose of
PBDE-99 and not in the second week of post-
natal development. When litter size was
included as a covariate in the analysis, the gen-
eral pattern of effects did not change much. All
signiﬁcant effects remained signiﬁcant, but a
few other differences between A1254 and the
PBDE-treated groups also became signiﬁcant
(p < 0.05) in both sexes (Table 1).
Organ weights. Organ weights are given in
Table 2. At weaning, there were no signiﬁcant
differences between PBDE-exposed and con-
trol rats in weights of brain, thymus, testis,
ventral prostate, and uterus. There was a ten-
dency for decreased pituitary weights in male
offspring at the higher dose level compared
with controls (p < 0.1), whereas the difference
Lilienthal et al.
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Table 1. Reproductive data of rats exposed to PBDE or A1254 (mean ± SE).
Age Control BDE01 BDE10 A1254
Dam body weight (g) GD8 203.7 ± 5.3 198.8 ± 5.3 203.9 ± 4.8 200.1 ± 5.8
GD10 214.7 ± 5.1 207.4 ± 4.9 212.5 ± 4.5 208.4 ± 5.4
GD20 279.8 ± 7.9 276.9 ± 5.2 282.8 ± 7.1 275.5 ± 6.8
Implantations 12.2 ± 0.5 12.1 ± 0.5 12.8 ± 0.4 11.9 ± 0.4
No. of litters 25 26 26 22
Pups per litter 10.4 ± 0.4 10.8 ± 0.4 11.8 ± 0.4 10.9 ± 0.5
Percent male 48.1 50.9 52.5 49.2
Pup body weight (g) PND0 5.9 ± 0.1 6.0 ± 0.1**  5.9 ± 0.1#  5.7 ± 0.1
Male PND7 14.0 ± 0.3 14.4 ± 0.2**  13.8 ± 0.3**  12.4 ± 0.3*
PND14 26.4 ± 0.5 27.0 ± 0.3**  26.8 ± 0.5**  25.1 ± 0.5
PND21 41.2 ± 1.5 42.1 ± 1.3#  41.9 ± 1.2#  37.7 ± 1.1
PND0 5.5 ± 0.1 5.7 ± 0.1*,**  5.5 ± 0.1 5.3 ± 0.1
Female PND7 14.2 ± 0.7 13.7 ± 0.2**  13.2 ± 0.3#  11.9 ± 0.3*
PND14 25.2 ± 0.6 26.0 ± 0.3#  25.6 ± 0.4 24.5 ± 0.5
PND21 39.0 ± 1.5 40.0 ± 1.2 39.7 ± 1.1#  36.3 ± 1.2
*p < 0.05 compared with control. **p < 0.05 compared with A1254. #p > 0.05 compared with A1254 after analysis of covariance
with litter size as the covariate.
Table 2. Relative organ weights (mean ± SE) in dams and weanling offspring. 
Organ Control BDE01 BDE10 A1254
Dams
GD19 Brain 6.5 ± 0.2 6.6 ± 0.1 6.3 ± 0.1 6.8 ± 0.1
Pituitary 38.8 ± 6.0 34.4 ± 4.6 33.4 ± 4.4 33.7 ± 6.0
PND21 Brain 6.9 ± 0.2 7.1 ± 0.2 7.1 ± 0.2 6.8 ± 0.3
Pituitary 36.4 ± 5.1 38.3 ± 6.9 41.2 ± 2.4 45.0 ± 2.9
Liver 51.9 ± 1.5 53.7 ± 1.5 52.1 ± 1.3 56.6 ± 1.6
Offspring, PND21
Female  Brain 35.8 ± 0.4 38.2 ± 1.4 35.2 ± 0.4 39.8 ± 4.8
Pituitary 73.4 ± 5.6 99.7 ± 9.5* 69.5 ± 7.9 84.0 ± 4.6
Thymus 3.76 ± 0.15 3.77 ± 0.10 3.80 ± 0.11 3.39 ± 0.17
Male
Brain 33.7 ± 2.9 34.9 ± 1.0 32.7 ± 1.0 35.5 ± 0.5
Pituitary 61.3 ± 11.4 72.7 ± 6.4 41.8 ± 5.4 (*),** 75.8 ± 6.8
Thymus 3.37 ± 0.19 3.79 ± 0.07** 3.43 ± 0.14** 2.80 ± 0.20*
Brain, liver, and thymus weights are given in g/kg body weight; pituitary, uterus, and ovary weights are given in mg/kg body
weight (GD19, n = 3/group; PND21, n = 6–8/group). 
*p < 0.05 compared with control. (*p) < 0.1 compared with control. **p < 0.05 compared with A1254.between the higher dose and A1254 males was
signiﬁcant (p < 0.05). In contrast, females of
the lower dose group exhibited significantly
increased pituitary weights compared with
controls (p < 0.05). A1254 exposure caused a
signiﬁcant decrease in thymus weight in male
pups compared with controls (p < 0.05). The
most remarkable effect seen in adult rats was
the reduction in thyroid weights in both sexes
after PBDE and A1254 exposure (Figure 1).
This effect was significant even at the lower
dose (p < 0.05) and more pronounced at the
higher one. Mean ovary weights (± SE) were
408 ± 13, 393 ± 22, 388 ± 17, and 344 ± 16
mg/kg body weight in controls, BDE01,
BDE10, and A1254 rats, respectively. The
decrease approached signiﬁcance in A1254 rats
compared with controls (p < 0.1). There were
no treatment-related effects on weights of other
organs or body weights in adult rats.
Anogenital distance and puberty onset.
Results for anogenital distance and puberty
onset are shown in Table 3. Exposure to
A1254 delayed puberty onset in both sexes
(p < 0.05), whereas the higher dose of
PBDE-99 caused a delay only in female off-
spring (p < 0.05). In contrast, the lower dose
resulted in a slight acceleration of puberty
onset in male rats compared with controls
(p < 0.1). Signiﬁcant differences between both
PBDE groups and A1254 rats (p < 0.05) were
found only in male rats, with puberty being
later in the A1254 group.
At weaning, anogenital distance was
decreased by A1254 exposure in both sexes
compared with controls (females p < 0.05,
males p < 0.1). In males, anogenital distance
decreased with increasing dose of PBDE and
approached statistical signiﬁcance (p < 0.1) in
the BDE10 group. These effects on anogenital
distance were persistent in adult males at
PND160 (Table 3). Anogenital distances of
weanling female rats from both PBDE groups
were significantly higher than those of the
A1254 female pups (p < 0.05) but did not dif-
fer from controls.
Ovarian follicles. A statistically signiﬁcant
reduction in the primordial/primary follicle
pool was observed in the BDE01 group
(p < 0.05), and a dose-related decrease in the
number of secondary follicles was seen in
females exposed to PBDE-99 that was signiﬁ-
cant in the BDE10 group (p < 0.05). Exposure
to A1254 resulted in a statistically signiﬁcant
increase in the number of tertiary follicles
compared with controls (p < 0.05) (Table 4).
Sex steroid concentrations. Circulating con-
centrations of estradiol and testosterone are
shown in Figure 2. Exposure-related differ-
ences in serum estradiol could be detected in
dams on PND21 [F(3,25) = 3.33, p < 0.05].
Estradiol concentrations were decreased by
about 37% and 53% in the BDE10 dams and
A1254 dams, respectively. Post hoc tests were
not signiﬁcant, but the decrease in A1254 rats
approached signiﬁcance (p < 0.1; Figure 2A).
Circulating testosterone was reduced in
BDE10 dams and A1254 dams by 33% and
22%, respectively, but these differences did not
reach statistical significance (Figure 2B).
Differences in serum estradiol approached sig-
nificance in female offspring on PND21
[F(3,26) = 2.36, p < 0.1], but post hoc tests
failed to show any statistical differences
(Figure 2C). Testosterone concentrations in
female pups were not altered by exposure
(p > 0.1; Figure 2D). In weanling males, circu-
lating estradiol was reduced in all treatment
groups [F(3,28) = 4.36, p < 0.05]. This reduc-
tion was more pronounced in the group
exposed to the higher dose, being approxi-
mately 34% and 44% in BDE01 and BDE10
males, respectively. The reductions in A1254
males measured 57% compared with controls
(Figure 2E). According to post hoc tests, the
difference to controls approached signiﬁcance
in BDE01 males (p < 0.1) and was signiﬁcant
in BDE10 and A1254 males (p < 0.05).
Circulating testosterone was reduced by about
50% of control values in all treated groups, but
due to high variability these differences failed
to reach significance (Figure 2F). Effects on
circulating sex steroids were even more pro-
nounced in adult males (Figure 2G, H). There
were reductions in serum concentrations of
estradiol [F(3,28) = 12.39, p < 0.0001] and
testosterone [F(3,28) = 3.00, p < 0.05]. The
reductions in estradiol concentrations were
more pronounced at the higher dose, being
52% and 79% in BDE01 and BDE10 groups,
respectively. A1254 males exhibited a reduc-
tion of 54%. Post hoc tests revealed signiﬁcant
differences for all treated groups compared
with controls (p < 0.05). Testosterone was
decreased by 45% and 60% in BDE01 and
BDE10 males, respectively, and by about 50%
in male rats exposed to A1254. Differences
were significant between BDE10 males and
controls according to post hoc tests (p < 0.05)
and approached significance in BDE01 and
A1254 males (p < 0.1).
Sweet preference. Exposure to PBDE-99
caused signiﬁcant increases in the ratio of sac-
charin-to-water consumption in male rats
[Figure 3A; F(3,36) = 2.87; p < 0.05]. Values
were increased by 14% and 45% in BDE01
and BDE10 groups, respectively, with a signif-
icant difference between BDE10 rats and con-
trols according to post hoc tests (p < 0.05).
Males exposed to A1254 did not differ from
controls, but the deviation from BDE10 males
was signiﬁcant (p < 0.05). In general, the ratio
of saccharin to water consumption was about
2-fold higher in female (Figure 3B) than in
male rats (Figure 3A), showing that this
Sex-related effects of developmental PBDE exposure
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Figure 1. Thyroid weights in male (A) and female (B) adult offspring after exposure to low and high doses
of PBDE-99 or A1254. Data shown are mean ± SE (n = 8/group).
*p < 0.05 compared with control.
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Table 3. Development of reproductive organs given as median (ﬁrst quartile, third quartile); n = 8/group.
Age Control BDE01 BDE10 A1254
Male offspring
Puberty onset (PND)  44.7 (44.0, 44.8) 44.3(*),# (43.0, 44.4) 44.3# (43.3, 45.0) 45.3* (45.0, 47.5)
Anogenital distance  PND21 3.57 (3.23, 3.79) 3.40 (3.21, 3.61) 3.26(*) (3.08, 3.41) 3.34(*) (3.04, 3.40)
PND160 6.95 (6.79, 7.12) 6.66 (6.53, 6.97) 6.69(*) (6.37, 6.99) 6.48* (6.18, 6.89)
Female offspring
Puberty onset (PND) 33.7 (33.6, 33.8) 34.2 (33.8, 34.3) 34.0* (33.9, 34.8) 34.4* (34.2, 34.7)
Anogenital distance PND21 2.03 (1.66, 2.08) 1.95# (1.69, 2.16) 1.83# (1.71, 2.03) 1.50* (1.41, 1.77)
Puberty onset is given for PND of preputial separation in males or vaginal opening in females (n = 10 litters/group). Anogenital distance was standardized to the cubic root of body weight and
is given as 10 × mm ÷ g1/3.
*p < 0.05 compared with control, (*) p < 0.1 compared with control, and #p < 0.05 compared with A1254, by Van der Waerden test.behavior is indeed sexually dimorphic. PBDE-
treated females exhibited some signs of super-
normality, with increases of about 8% in the
BDE01 group and 30% in the BDE10 group,
but these differences were not signiﬁcant.
Analysis of PBDE-99 in tissues. Results of
PBDE-99 tissue levels are shown in Table 5.
From the day after the last treatment (GD19)
to weaning (PND21), the concentrations
decreased in the brain and adipose of dams.
On PND21, PBDE-99 concentrations in the
brain reached control levels in BDE01 dams,
whereas there was a reduction to approxi-
mately 25% of initial values in brains of
BDE10 dams. Decreases of approximately
48% and 10% were observed in adipose tissue
of BDE01 and BDE10 dams, respectively.
Compared with those of dams, brain levels of
PBDE-99 were lower by factors of 7–9 in off-
spring on GD19. Similar to those of dams,
brain concentrations declined to control values
in low-dosed male and female offspring by
PND21. In the BDE10 group, brain concen-
trations in male and female offspring were
lower than those of dams by factors of 3–7. In
adipose tissue, the concentrations were lower
by factors of 6–17 and 13–38 in BDE01 and
BDE10 offspring, respectively. Internal PBDE
concentrations in males were slightly higher
than in females on PND21, but the differ-
ences are still within analytical statistical varia-
tion. On PND160, brain concentrations were
indistinguishable from controls in both
PBDE-treated groups, whereas there was still a
detectable elevation in adipose tissue of
BDE10 males.
Discussion
Gestational exposure to PBDE-99 did not
affect reproductive success in dams or develop-
ment of body weights in offspring at the doses
tested. The weights of nonreproductive and
reproductive organs were largely unchanged;
however, we found increased pituitary weights
at the low dose in female offspring and
decreased weights at the high dose in male off-
spring. This may indicate a biphasic response
to PBDE exposure, in particular, because we
found small nonsignificant increases in low-
dose males, as well. A similar biphasic response
has been reported for anterior pituitary weights
in male rats after exposure to the commercial
PBDE mixture DE-71 using a pubertal proto-
col (Stoker et al. 2004). In our rats, these
changes were transient, because they were not
observed in adulthood in the male offspring.
A marked effect was the decrease in thyroid
weights in adult offspring, which was more
pronounced in the high-dose group. However,
PBDE effects on the thyroid were not the
main focus of our study. There are several
reports on decreased circulating concentrations
of thyroid hormones after developmental expo-
sure to PBDE mixtures and single congeners in
mice and rats (Kuriyama et al. 2005; Skarman
et al. 2004; Zhou et al. 2002). The reasons for
decreased thyroid hormones are not entirely
clear because the proposed mechanisms—
induction of thyroid-metabolizing uridine
diphosphate-glucuronosyltransferase
(UDP-GT) and competitive binding to serum
transport proteins—are not sufficient to
explain hormone reductions in certain animal
models after exposure to PCBs (Kato et al.
2004). Reduced thyroid hormone concentra-
tions recover within 2–3 weeks after termina-
tion of exposure of rats after weaning (Stoker
et al. 2004; Zhou et al. 2002), whereas in the
present study we found the reduced thyroid
weights in adult rats long after the end of the
developmental treatment when internal con-
centrations of PBDE-99 had declined to nearly
control values.
The delay of puberty onset we observed in
female rats at the higher dose of PBDE-99 is in
accordance with results of pubertal exposure to
the technical PBDE mixture DE-71 (Stoker
et al. 2004). However, in males we detected a
small acceleration at the lower dose of PBDE-
99, in contrast to the dose-dependent delay
reported for DE-71. This discrepancy may be
related to the different substances used for
exposure or to the different exposure periods.
Although PBDE-99 is the major constituent of
DE-71 (48%), only a slightly smaller propor-
tion of this mixture is composed of tetrabromi-
nated PBDE-47 (37%) and pentabrominated
PBDE-100 (8%) (Sjödin et al. 2003). These
latter congeners, like DE-71, are reported to
inhibit dihydrotestosterone-induced transcrip-
tional activation of the human androgen recep-
tor (AR) in vitro in the micromolar range. This
was not observed for PBDE-99, although it
exhibits competitive binding to the AR (Stoker
et al. 2005). Thus, the different antiandrogenic
activities of DE-71 and PBDE-99 may underlie
the divergent effects observed for puberty onset
in males. On the other hand, the inﬂuence of
Lilienthal et al.
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Table 4. Median ovarian follicle numbers in 220-day-old female offspring given as median (first quartile,
third quartile); n = 8/group. 
Primordial/primary Secondary Tertiary Atretic
Control 48 (46.5, 59.0) 12 (8.0, 13.5) 6 (5.0, 9.0) 2 (1.5, 2.5)
BDE01 34 (28.5, 45.0)* 9 (6.5, 14.5) 10 (7.5, 11.5) 2 (0.0, 4.0)
BDE10 47 (35.5, 64.0) 6 (5.5, 8.0)* 8 (7.0, 9.0) 2 (1.5, 3.5)
A1254 42 (34.0, 52.0) 11 (4.5, 13.5) 10 (8.5, 11.5)* 2 (1.0, 3.0)
*p < 0.05 compared with control, by Van der Waerden test.
Figure 2. Serum concentrations (mean ± SE) of estradiol (A, C, E, G) and testosterone (B, D, F, H) in dams on PND21 (A, B), female offspring on PND21 (C, D), male
offspring on PND21 (E, F), and male offspring on PND160 (G, H). n = 8/group.
*p < 0.05 compared with control. (*)p < 0.1 compared with control.
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pubertal) cannot be excluded. The mechanism
behind the accelerated puberty onset in males
exposed to PBDE-99 remains to be deter-
mined. Because both testosterone and estradiol
levels were reduced in male offspring, the
observed effect may be due to an imbalance in
the relation of androgen to estrogen levels dur-
ing prenatal and early postnatal development.
Alternatively, PBDE-99 may interact with epi-
dermal growth factors that have been shown to
result in accelerated preputial separation
(Henck et al. 2001) via stimulation of the
release of gonadotropin releasing hormone by
prostaglandin-E2 (Ojeda and Ma 1998). The
reductions in circulating concentrations of sex
steroids in the weanling and adult male off-
spring resemble similar decreases found after
exposure to a reconstituted PCB mixture
(Hany et al. 1999; Kaya et al. 2002). Although
several actions on enzymes involved in steroid
synthesis and metabolism have been described
for PCBs, such data are lacking for PBDEs. In
the present study, decreased steroid concentra-
tions became more pronounced in adult males,
thus demonstrating a long-lasting effect.
Interplay between the hypothalamo–pitu-
itary–thyroid axis and the ovary has been
demonstrated as disturbed folliculogenesis has
been reported in mice and rats treated post-
natally with 6-propyl-2-thiouracil, an agent
used to treat hyperthyroidism (Chan and Ng
1995; Dijkstra et al. 1996). In addition,
intraperitoneal administration of 2.5 mg
Aroclor 1016/kg/day on GD7–13 (Baldridge
et al. 2003) led to a reduction in preantral and
antral follicles, with the reduction not occur-
ring in the preantral group when thyroxine
was simultaneously administered with Aroclor
1016. Similar to these ﬁndings, we observed a
reduction in the primordial/primary follicles
in the BDE01 group and a decrease in sec-
ondary follicles in the BDE10 group. A func-
tional consequence of a decrease in the resting
follicle pool could be a shorter reproductive
life span because the size of the resting follicle
pool is believed to be a major determinant of
ovarian senescence. We observed an increased
number of tertiary follicles in the A1254
group, indicating altered maturation or pro-
longation of this phase by postponement of
atresia. Thus, the observed changes in follicle
numbers may be related to thyroid effects
because thyroid weights were decreased in
exposed rats. On the other hand, the altera-
tions in folliculogenesis and prepubertal
steroidogenesis may indicate disruption along
the hypothalamo–pituitary–ovarian axis
after exposure to either PBDE-99 or A1254.
Follicle-stimulating hormone (FSH) is respon-
sible for follicular growth and differentiation
of granulose cells that surround oocytes during
the entire follicular development. Therefore,
changes in gonadotropin levels or a direct
effect of PBDE on granulosa cells, leading
to alterations in FSH receptors on these
cells, could affect follicular maturation.
Influences on gonadotropin concentrations
were described after exposure to PCBs in
female (Lyche et al. 2004) and male mammals
(Desaulniers et al. 1999). Additional data are
needed to clarify if effects on the production
of FSH or alterations in FSH receptors are
involved in disturbances of folliculogenesis by
PBDE-99.
The increased sweet preference seen after
exposure to PBDE-99 in adult male offspring
is similar to effects seen after treatment with a
PCB mixture reconstituted according to the
congener pattern found in human milk (Hany
et al. 1999; Kaya et al. 2002). This behavior is
sexually dimorphic, with females demonstrat-
ing a higher preference for sweet, such that an
elevation in the intake of the sweetened water
by the males indicates behavioral feminization.
For PCBs, increased sweet preference was
related to inﬂuences on sexual differentiation
of the brain, demonstrated by decreased activ-
ity of hypothalamic aromatase in newborn
male pups (Hany et al. 1999). The peak of
aromatase activity is around birth, and the
resultant increase in the local conversion of
testosterone to estradiol is one of the key
processes in the male-like differentiation of the
rodent brain and subsequent sexually dimor-
phic behavior (e.g., Hutchison et al. 1999;
Negri-Cesi et al. 2004). At present, there are
no data on aromatase activity in developing
rats exposed to PBDE-99, but preliminary
results of a study following the same protocol
as in the present study indicate alterations in
steroid receptor mRNA levels in brain regions
related to sexual functions in rats exposed to
PBDE-99 (Lichtensteiger et al. 2003).
The PBDE-99 used in the present study
has been analyzed for impurities, and all
results for brominated dioxins, furans, and
coplanar polybrominated biphenyls were
below the detection limits. However, in the
worst case this could mean that the PBDE-99
used might contain brominated dibenzofu-
rans and dioxins at a level of about 0.50 µg
TEQ/g PBDE-99. This would have resulted
in a total TEQ exposure of 4.5 and 45 ng/kg
body weight in the BDE01 and BDE10
groups, respectively. However, a much higher
TEQ value of 39.42 µg/g was reported for a
low-contaminated lot of A1254 (Kodavanti
et al. 2001), and the A1254 doses used in our
study were 3- and 30-fold higher than the
respective doses of PBDE-99. Moreover,
some of the end points in this study, such as
pituitary weight and sweet preference in male
offspring and primary and secondary follicles
in female offspring, were affected by PBDE-
99 but not by A1254. The lack of ability of
A1254 to alter sweet preference has been pre-
viously detected in our laboratory (Hany et al.
1999). In that study, A1254 was compared
with a PCB mixture that was reconstituted
Sex-related effects of developmental PBDE exposure
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Figure 3. Saccharin-to-water consumption ratio (mean ± SE) in adult male offspring (A; n = 9–11/group)
and adult female offspring (B; n = 10–12/group). 
*p < 0.05 compared with control.
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Table 5. Tissue concentrations (mean ± SE, µg/g wet weight) of PBDE-99 (n = 3/group). 
Age Control BDE01 BDE10 A1254
Dams
Brain GD19 0.010 ± 0.004 0.372 ± 0.034 4.090 ± 0.319 0.005 ± 0.003
PND21 0.005 ± 0.001 0.018 ± 0.007 1.148 ± 0.615 0.016 ± 0.003
Adipose GD19 0.015 ± 0.005 5.103 ± 1.754 88.200 ± 23.477 0.014 ± 0.003
PND21 0.010 ± 0.008 2.672 ± 1.430 78.200 ± 32.456 0.010 ± 0.005
Offspring
Brain GD19 0.013 ± 0.004 0.053 ± 0.008 0.465 ± 0.140 0.010 ± 0.002
Female offspring
Brain PND21 0.024 ± 0.017 0.021 ± 0.003 0.175 ± 0.062 0.021 ± 0.012
Adipose  PND21 0.031 ± 0.020 0.159 ± 0.031 2.052 ± 0.949 0.003 ± 0.001
Male offspring
Brain PND21 0.036 ± 0.022 0.036 ± 0.008 0.376 ± 0.139 0.048 ± 0.016
PND160 0.006 ± 0.003 0.003 ± 0.001 0.008 ± 0.006 0.004 ± 0.002
Adipose  PND21 0.019 ± 0.001 0.429 ± 0.207 6.020 ± 1.859 0.009 ± 0.004
PND160 0.003 ± 0.001 0.026 ± 0.002 0.140 ± 0.003 0.004 ± 0.001Lilienthal et al.
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according to the congener pattern found in
human breast milk and included coplanar and
mono-ortho-chlorinated PCBs. Thus, differ-
ences in TEQ content are unlikely to account
for the results. Moreover, developmental
exposure to 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) or coplanar PCBs did not
affect sweet preference in male rats but caused
masculinization of this behavior in female rats
(Amin et al. 2000). This suggests that the
inﬂuence of PBDE-99 on sweet preference in
the present study cannot be ascribed to aryl
hydrocarbon (Ah) receptor activity of conta-
minants. There are other effects of PBDEs for
which mediation by Ah receptor activity is
not likely. Only PBDE-99, and not A1254,
was reported to cause apoptotic cell death in
astrocytoma cells (Madia et al. 2004), and the
PBDE mixture DE-71 caused disturbance of
protein kinase C activation and calcium
homeostasis in neuronal cell preparations,
measures that are not inﬂuenced by coplanar
PCBs (Kodavanti et al. 2005).
From the tissue concentration data, it
appears that PBDE-99 is more rapidly
removed than are PCBs. Values in the brain
of offspring were highest at GD19. This is in
contrast to previously reported results with
the reconstituted PCB mixture (Kaya et al.
2002; Lilienthal et al. 2000), where there was
an increase in brain concentrations in off-
spring until weaning. Also, the decline of
PBDE-99 concentrations in adipose tissue of
dams during lactation and in male offspring
from weaning to adulthood appears to be
more pronounced. Further investigations
should clarify if this holds true only for
PBDE-99 or if PBDE congeners are generally
less stable in the mammalian body than their
respective PCB congeners. The internal expo-
sure values found in adipose tissue of dams in
this study are higher by factors of about 8–15
in the low-exposure group than the 95th per-
centile of the total PBDE concentration
found in human breast milk in the United
States (Schecter et al. 2003). In Europe, these
factors are approximately 10–100 times
higher than in North America (Meironyte
Guvenius et al. 2001; Meneses et al. 1999).
Conclusions
The present results indicate an endocrine-
modulating activity of PBDE-99. Effects on
several end points, including anogenital dis-
tance, sex steroid concentrations, and sweet
preference in male rats as well as ovarian folli-
cle number in female rats, were detected in
adulthood long after the termination of expo-
sure demonstrating the persistence of effects
after developmental treatment. Some of the
alterations induced by PBDE-99 are not
likely to be due to TEQ impurities because
A1254 and PBDE-99 exposure resulted in
different patterns of effects.
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